DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Motzer RJ, Tannir NM, McDermott DF. , et al; CheckMate 214 Investigators.
Nivolumab plus Ipilimumab versus Sunitinib in advanced renal-cell carcinoma.
N Engl J Med 2018;
378 (14) 1277-1290
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.